Kyowa Hakko Kirin Expands Nespo Use To Predialysis Patients
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin obtained an additional indication for Nespo (darbepoetin alpha) for predialysis in patients with renal anemia to slow progress of renal failure
Kyowa Hakko Kirin obtained an additional indication for Nespo (darbepoetin alpha) for predialysis in patients with renal anemia to slow progress of renal failure. The drug works to increase red blood cells and is currently used for patients on dialysis. Compared to the current intravenous injection, the new Nespo indication is a once-weekly injection for chronic renal disorder. (Click here for more - Japanese language) "Kyowa Hakko Kirin Expands Nespo Use To Pre-dialysis Renal Anemia Patients" - Nikkei Sangyo News (8/31/2010) |